GEHC: GE HealthCare Technologies Inc. Stock

by  •  • Comments Off on GEHC: GE HealthCare Technologies Inc. Stock

SIC 3844 – X-Ray Apparatus and Tubes and Related Irradiation Apparatus

Valuation
Market Cap ($M) 35,712.25
Enterprise Value ($M) 42,595.25
Book Value ($M) 7,599.00
Book Value / Share 16.65
Price / Book 4.70
NCAV ($M) -15,236.00
NCAV / Share -33.39
Price / NCAV -2.34

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.23

Liquidity (mrq)
Quick Ratio 0.83
Current Ratio 1.06

Balance Sheet (mrq) ($M)
Current Assets 9,373.00
Assets 32,208.00
Liabilities 24,609.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 19,552.00
Operating Income 2,435.00
Net Income 1,568.00

Cash Flow Statement (mra) ($M)
Cash From Operations 2,101.00
Cash from Investing -558.00
Cash from Financing -478.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-02 13G/A General Electric Co 6.70 -50.42
03-11 13G/A Vanguard Group Inc 10.21 4.72
02-09 13G/A Capital Research Global Investors 11.30 8.05
01-29 13G BlackRock Inc. 6.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P
2024-02-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number 001-41528 GE H
2023-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPO
2023-07-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PU

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 559,494 2,309,594 24.22
2024-05-01 862,270 1,955,028 44.11
2024-04-30 3,477,188 4,376,110 79.46
2024-04-29 856,936 1,645,688 52.07

(click for more detail)

Similar Companies
CVRX – CVRx, Inc. DXCM – DexCom, Inc.
EMBC – Embecta Corp. HOLX – Hologic, Inc.
IART – Integra LifeSciences Holdings Corporation


Financial data and stock pages provided by
Fintel.io